Metropolis Healthcare Ltd (METROPOLIS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 542650 | NSE: METROPOLIS | Hospital & Healthcare Services | Small Cap

Metropolis Health. Share Price

1,918.35 -11.05 -0.57%
as on 05-Dec'25 15:26

Metropolis Healthcare Ltd (METROPOLIS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 542650 | NSE: METROPOLIS | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Metropolis Health.

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Metropolis Healthcare stock performance -

Key Ratios
mw4me loader
P/E Ratio (CD):
63.19
Market Cap:
9,998.5 Cr.
52-wk low:
1,383.7
52-wk high:
2,259.3

Is Metropolis Healthcare Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Metropolis Health.: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Metropolis Healthcare Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 40.1%54.3%45.2%44.8%37.8%41.6%34.4%19.8%18.7%17.6%-
Value Creation
Index
2.03.02.42.21.82.11.60.50.40.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 5245456477618569981,2281,1481,2081,3311,483
Sales YoY Gr.-4%18.8%17.6%12.5%16.5%23.1%-6.5%5.2%10.2%-
Adj EPS 1619.620.924.125.236.239.827.925.827.930.5
YoY Gr.-22.5%6.4%15.6%4.3%43.8%9.9%-29.8%-7.7%8.4%-
BVPS (₹) 53.465.183.282.9103136.6170.9191.5212.5255.4276.4
Adj Net
Profit
79.597.4104121127185203143132145158
Cash Flow from Ops. 88.210210490.2215249253247264263-
Debt/CF from Ops. 0.1000.20010.300.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 10.9%9.2%2.7%10.2%
Adj EPS 6.4%2.1%-11.1%8.4%
BVPS19%19.9%14.3%20.2%
Share Price - -0.8% 9.7% -8.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
25.433.128.129.12730.125.615.312.711.911.5
Op. Profit
Mgn %
26.228.4282727.829.328.325.724.423.322.4
Net Profit
Mgn %
16.818.917.216.414.918.616.612.51110.910.7
Debt to
Equity
0000000.30.1000
Working Cap
Days
828216021818712711615313715741
Cash Conv.
Cycle
2218233318-8-90-2-46

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Metropolis Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 25.8 30.5
TTM Sales (₹ Cr.) 1,288 1,483
BVPS (₹.) 256.2 276.4
Reserves (₹ Cr.) 1,317 1,422
P/BV 7.53 6.98
PE 74.91 63.19
From the Market
52 Week Low / High (₹) 1383.70 / 2259.30
All Time Low / High (₹) 904.85 / 3579.00
Market Cap (₹ Cr.) 9,999
Equity (₹ Cr.) 10.4
Face Value (₹) 2
Industry PE 90.5

Management X-Ray of Metropolis Health.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *1.181.181.181.181.181.181.181.181.181.18
* Pledged shares as % of Promoter's holding (%)

Valuation of Metropolis Health. - Consolidated Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Metropolis Health.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales5245456477618569981,2281,1481,2081,331
Operating Expenses 3883914695576197088838579201,023
Manufacturing Costs18202930354663466269
Material Costs143135146174204252276253243269
Employee Cost 116128147176190199233253276314
Other Costs 111108147177190211310305339371
Operating Profit 136153178204237290346291288308
Operating Profit Margin (%) 26.0%28.2%27.6%26.8%27.7%29.0%28.1%25.4%23.8%23.2%
Other Income 2226889122017915
Interest 2244131225322824
Depreciation 211719203946638994109
Exceptional Items -8000-25016000
Profit Before Tax 128160164187169244293188175191
Tax 46535263416179444645
Profit After Tax 82107112124128183215143128146
PAT Margin (%) 15.6%19.7%17.3%16.2%14.9%18.4%17.5%12.5%10.6%10.9%
Adjusted EPS (₹)14.820.521.023.925.235.841.927.925.028.0
Dividend Payout Ratio (%)104%49%0%55%32%22%19%29%16%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 2653234134165216988749811,0881,323
Share Capital 10101010101010101010
Reserves 2553144044065116888649711,0781,313
Minority Interest2021141212234
Debt31118002597905
Long Term Debt3000001592905
Short Term Debt00018001005000
Trade Payables38363543851111039499126
Others Liabilities 65131346325322249507554557809
Total Liabilities 3915128108039301,0591,7451,7101,7482,266

Fixed Assets

Gross Block2732202462713664381,2231,3441,4931,877
Accumulated Depreciation1251739587095165224316430
Net Fixed Assets 1482022072132963431,0591,1211,1771,447
CWIP 11063062000
Investments 8014210233141016155571
Inventories18142126244151453948
Trade Receivables7780101137128123135122126148
Cash Equivalents 43416080210420167937149
Others Assets 2532318308253123311296280504
Total Assets 3915128108039301,0591,7451,7101,7482,266

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 8810210490215249253247264263
PBT 128160164187169244293188175191
Adjustment 9-32122837759104121132
Changes in Working Capital -3-4-23-5128-15-1675-16
Tax Paid -47-51-58-67-64-57-83-52-37-44
Cash Flow From Investing Activity 91-86235-10562-73847-89-201
Capex -13-16-18-23-36-28-31-52-64-67
Net Investments 104-371756-7385-8093-27-5
Others -1-333345-62762-130
Cash Flow From Financing Activity -166-17-87-118-55-33163-292-181-87
Net Proceeds from Shares 000-332342000
Net Proceeds from Borrowing 0-4-0-0-180159000
Interest Paid -1-0-0-0-41-7-18-27-22-19
Dividend Paid -84-0-53-67-8-41-41-41-200
Others -81-13-34-48-21-1961-224-138-68
Net Cash Flow 13-119755278-3222-7-25

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)26.1636.4730.3829.8227.2130.0727.3115.4612.4212.07
ROCE (%)40.0654.2845.2244.7737.7941.634.3919.8318.7317.59
Asset Turnover Ratio1.221.210.980.940.9910.880.660.70.66
PAT to CFO Conversion(x)1.070.950.930.731.681.361.181.732.061.8
Working Capital Days
Receivable Days53535157564638413838
Inventory Days13111011111214151312
Payable Days921008982114142141142146153

Metropolis Healthcare Ltd Stock News

Metropolis Healthcare Ltd FAQs

The current trading price of Metropolis Health. on 05-Dec-2025 15:26 is ₹1,918.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Metropolis Health. stood at ₹9,998.5.
The latest P/E ratio of Metropolis Health. as of 04-Dec-2025 is 74.91.
The latest P/B ratio of Metropolis Health. as of 04-Dec-2025 is 7.53.
The 52-week high of Metropolis Health. is ₹2,259.3 and the 52-week low is ₹1,383.7.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Metropolis Health. is ₹1,288 ( Cr.) .

About Metropolis Healthcare Ltd

Metropolis Healthcare Limited is one of leading and renowned Indian diagnostics companies. The company owns a chain of diagnostic ce9ntres across India, South Asia, Africa and the Middle East. Over the years, Metropolis has carved a niche for itself. The company enjoys a loyal customer base, reflecting its strength as a brand offering superior diagnostic tests and services.

With its widespread operational network, Metropolis offers a comprehensive range of clinical laboratory tests and profiles. These tests and profiles are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. Metropolis plays a pivotal role in raising the bar of diagnostic accuracy, technological equipment, customer experience and research-driven empathetic service in the industry.

Business area of the company

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine’ tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized’ tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.

Services

  • Pathology Testing Services
  • Corporate Wellness
  • Lab in Hospitals
  • Clinical Research Services

Awards

FY2018-19

  • The Global Reference Laboratory of Metropolis holds accreditation from the College of American Pathologists (CAP) since 2005 which is the gold standard in accreditations in industry, globally.
  • Metropolis Healthcare was awarded Iconic Pathology Lab Award by Mid-Day Health & Wellness Awards in September 2018
  • Metropolis received the ‘Best Diagnostic Laboratory’ in India award at the Women’s Health Conference 2019
  • Metropolis was awarded special jury mention for “Service Excellence (Diagnostic Centre)” by FICCI at the Healthcare Excellence Awards 2018
  • Metropolis Healthcare won the Best Temperature Controlled Project of the year at the Cold Chain Summit Awards held in Mumbai, 2018
  • Metropolis Healthcare honored for Excellence in Customer Service & Delivery at the Home Healthcare Summit & Awards 2018
  • Company was awarded for “Best in Health and Fitness” in the Digital Campaign Awards by LH Insights 2018.

FY2019-20

  • Accorded as the Most Admired Healthcare Company of The Year - February 2020
  • Won the award for Best It Practices at the Data Center Summit 2019 - October 2019
  • Awarded as the Best Patient Experience Team Of The Year Award at PEXA Awards 2019, in Delhi - December 2019
  • Won the Healthcare Leadership Award, at the Uttar Pradesh Healthcare Leadership Awards 2019 held at Lucknow - October 2019
  • Bagged Excellence In Logistics award at the CII SCALE Awards 2019 - Supply Chain & Logistics Excellence Awards organised by Confederation of Indian Industries - December 2019
  • Awarded the Best It Enabled Pathology Chain Award during the 4th Digital Innovation Health Summit and CIO Awards at Kolkata
  • Won a special mention as the Best Performance-Driven Digital Campaign Award at the InkSpell Drivers of Digital Awards 2019 - December 2019
  • Conferred the Best Logistics Network Optimization & Best Use Of Technology In Logistics awards announced at the 5th Asian Supply Chain Thought Leadership Summit & Awards in Mumbai - November 2019

Major Events & Milestones

  • 2002: First major acquisition by company of Sudharma.
  • 2004: The company was accredited by National Accreditation Board for Testing and Calibration Laboratories (Department of Science & Technology, India).
  • 2005: The company received accreditation from The College of American Pathologists.
  • 2006: Investment by The Western India Trustee and Executor company in company.
  • 2006: Acquisition of Lister Laboratory and Research Centre Private Limited in Chennai.
  • 2007: Acquisition of Desai Clinical Laboratory in Surat.
  • 2008: Acquisition of R.V Diagnostics & Healthcare Center Private Limited in Bangalore.
  • 2010: Investment by Foxcreek Investment Limited in company.
  • 2012: Acquisition of Micron Laboratories in Mumbai.
  • 2012: Incorporation of subsidiary in Mauritius.
  • 2013: Establishment of GRL in Mumbai.
  • 2014: Acquisition of subsidiary in Ghana.
  • 2015: Investment by CA Lotus Investments in company.
  • 2015: Incorporation of subsidiary in Uganda.
  • 2015: Incorporation of branch office in Zambia.
  • 2017: Acquisition of Sanjeevani Pathology Laboratory in Rajkot.
  • 2018: 2018 Public-Private partnership agreement executed with National AIDS Control Organisation, Government of India.
  • 2018: Scheme of Amalgamation 2018.
  • 2018: Incorporation of subsidiary in Tanzania.
  • 2020: Metropolis Healthcare executes pact to acquire 51% stake in Shraddha Diagnostic Centre
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×